N/A N=68 Systane® Complete Preservative Free Lubricant Eye Drops
Dry Eye
Primary: Mean Overall Impact of Dry Eye on Everyday Life Symptom Bother (IDEEL SB) Score - By Dry Eye Group — 41.36; 47.08; 47.63; 31.26 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=30 Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer
Non-small Cell Lung Cancer (NSCLC)
Primary: Number of Patients Treated in Compliance With Protocol — 29 Participants
Phase 1 N=26 A Study of a New Vaccine Against Two Types of Ebola
Ebola
Primary: Safety and Tolerability of ChAdOx1 biEBOV in Healthy Volunteers: Number of Participants With Occurrence of Solicited Local and Systemic Reactogenicity Signs and Symptoms…
Phase 2 N=171 Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)
Relapsed or Refractory Peripheral T Cell Lymphoma
Primary: Part B: CT-based Objective Response Rate (ORR) by Independent Review Committee (IRC) — 43.1 percentage of participants — p=<0.0001
N/A N=1,249 Patient-Reported Outcome Measurement in Heart Failure Clinic
Heart Failure
Primary: Kansas City Cardiomyopathy Questionnaire-12 Score — 79.4; 79.7 score on a scale
Phase 3 N=108 Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor
Spasmodic Dysphonia · Voice Tremor
Primary: Symptom Severity — 28.0; 18.6; 14.2; 12.3 score on a scale — p=0.01
N/A N=362 Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System
Atrial Fibrillation
Primary: Pivotal Main Phase Modified Intent-To-Treat (mITT) Analysis Set: Number of Participants With Primary Adverse Events (PAEs) — 8 Participants
Phase 3 N=1,291 A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec
Diabetes Mellitus, Type 2
Primary: Change in Glycated Haemoglobin (HbA1c) — -1.60; -0.90 Percentage point of HbA1c — p=<0.0001
N/A N=41 Examining the Active Ingredients of Consultation of a Parent-mediated Intervention for Autism
Autism Spectrum Disorder
Primary: Treatment Adherence — 62.51 score on a scale — p=<.05
N/A N=17 Effects of Radiofrequency Ablation of Posterior Nasal Nerves on Inflammatory Cytokines, Peak Nasal Inspiratory Flow, and Nasal Blood Flow in Patients With Chronic Rhinitis
Chronic Rhinitis
Primary: Nasal Congestion as Assessed by the Peak Nasal Inspiratory Flow (PNIF) — 90 Liters Per Minute
N/A N=600 Continuing the Conversation: Using Narrative Communication to Support Hypertension Self-management in African American Veterans
Hypertension
Primary: BP Measurement Change at Follow-up — 132; 133; 80; 78 mmHg
N/A N=56 Sequences of Aerobic and Resistance Exercise and Cardio-metabolic Functions in T2D
Type 2 Diabetes
Primary: Fasting Glucose at Baseline — 7.2; 7.0 mmol/L
Phase 3 N=150 Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
Obesity
Primary: Change in Body Weight (%) : In-trial Observation Period — -16.4; -2.6 Percentage of body weight — p=<0.0001
N/A N=78 Community Active and Healthy Families
Obesity, Childhood
Primary: %BMIp95 — 122.35 percent of the 95th percentile of BMI — p=0.29
N/A N=60 Low-level Laser and Lifestyle Modifications
Overweight and Obesity · Weight Loss
Primary: Change in Fat Mass From Baseline to 6 Weeks — -1.3; -2.0 Kg — p=0.19